Trial Profile
A Study to Evaluate the Efficacy and Safety of Irinotecan Plus S-1 (IRIS) Therapy in Patients With Advanced/Recurrent Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Dec 2015 New trial record